| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -145.05K | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ORY.MC returned +3.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -8.2% |
| 1 year | +3.6% |
| 5 years | -18.9% |
| 10 years | -0.1% |
| All-time high | €4.82 (Jun 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in ORY.MC would be worth today ›No. Oryzon Genomics S.A. has not paid a dividend in the past 12 months.
Oryzon Genomics S.A. is part of the Healthcare sector.
Oryzon Genomics S.A. has a market cap of 232.43M EUR, based on the latest quote.
